Shelley A. Hall, M.D., is the Director of Heart Transplant Services for HeartPlace.
Dr. Lenhoff specializes in Cardiovascular Disease.
Dr. Johnson specializes in Interventional Cardiology, Vascular Medicine, Cardiovascular Disease and Endovascular Medicine.
Dr. Nesbitt attended Baylor University where he received his undergraduate degree.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
New findings from large-scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person's age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that diabetes is a major risk factor for developing these diseases, even in patients without heart disease.
The U.S. Food and Drug Administration has approved the VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent. Source: Medical News Today Read More Read More
Researchers at the MedUni Vienna's University Department of Anaesthetics, General Intensive Care Medicine and Pain Therapy, the University Department of Internal Medicine III and the Centre for Medical Statistics, Information Technology and Intelligent Systems have developed the world's first prognosis scoring system (PANDORA score) for hospital patients and their life expectancy within the next 30 days. This is the first specific undertaking from the "nutritionDay worldwide" project, launched ten years ago by Michael Hiesmayr, Head of the Clinical Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care Medicine, in collaboration with Karin Schindler at the MedUni Vienna. Source: Medical Xpress Read More Read More
While heart disease is the number one cause of death in both sexes, it poses special considerations in women—with risks often beginning in childhood and changing at different stages of life. Insights on cardiovascular disease (CVD) risk in women and girls throughout the life span are shared in a special symposium feature in the June issue of The American Journal of Medical Sciences. Source: Medical Xpress Read More Read More
Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. Now researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 labeled ligand is a promising approach for diagnostic imaging.
Source: Science DailyRead More